Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2004
09/23/2004WO2004080146A2 A marker system for characterizing undifferentiated human embryonic stem cells
09/23/2004WO2004072293A3 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor
09/23/2004WO2004071464A8 Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells
09/23/2004WO2004065602B1 Method of identifying the epithelial-mesenchymal transition of mesothelial cells (emtmc) and identifying emtmc-modulating compounds, pharmaceutical compositions and use thereof in the diagnosis and treatment of diseases associated with emtmc
09/23/2004WO2004060320A8 Methods of improving health-related quality of life in individuals with systemic lupus erythematosus
09/23/2004WO2004060052A3 Transgenic mice expressing human cd20 and/or cd16
09/23/2004WO2004055198A3 Device and method for in-line blood testing using biochips
09/23/2004WO2004053457A3 Quantitative test for bacterial pathogens
09/23/2004WO2004050870A3 Genetic switches for the detection of fusion proteins
09/23/2004WO2004048603A3 Coatings
09/23/2004WO2004044587A3 Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5)
09/23/2004WO2004044555A3 Diagnosis of sepsis or sirs using biomarker profiles
09/23/2004WO2004042390A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
09/23/2004WO2004042388A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a)
09/23/2004WO2004035784A3 Soluble rna polymerase protein and methods for the use thereof
09/23/2004WO2004031415A3 Methods and compositions for rapid development of screening assays nuclear receptors
09/23/2004WO2004029575A3 Methods for diagnosing htlv-i-mediated diseases
09/23/2004WO2004027092A3 Dna chips used for bioprocess control
09/23/2004WO2004023973A3 Molecules for diagnostics and therapeutics
09/23/2004WO2004018710A3 Diagnosis of chronic rejection
09/23/2004WO2004016744A3 Treatment of liver deseases
09/23/2004WO2004015391A3 Mass spectrometry-based identification of proteins
09/23/2004WO2004009782A3 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics
09/23/2004WO2003106968A3 Test strip for detection of analyte and methods of use
09/23/2004WO2003104481A3 Method for designing pdk1 modulators
09/23/2004WO2003104479A3 Identification of inhibitors of mitosis
09/23/2004WO2003100035A3 Method for rapid detection and identification of viral bioagents
09/23/2004WO2003096969A3 Novel lambda phage display system and the process
09/23/2004WO2003095671A8 Method of diagnosis and treatment for affective disorders
09/23/2004WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds
09/23/2004WO2003087815A3 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein
09/23/2004WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer
09/23/2004WO2003086174A3 A new method for the diagnosis and prognosis of malignant diseases
09/23/2004WO2003085096A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/23/2004WO2003085083B1 Liver necrosis predictive genes
09/23/2004WO2003061681A3 Proteins involved in the regulation of energy homeostasis and organelle metabolism
09/23/2004WO2003046136A3 Single tube screen
09/23/2004WO2003021223A3 Methods for qualitative and quantitative analysis of cells and related optical bio-disc systems
09/23/2004WO2003020907A3 Histamine receptor h4 polynucleotides
09/23/2004WO2003007801A3 Diagnosis and treatment of vascular disease
09/23/2004WO2003000920A3 Methods for characterization of nucleic acid molecules
09/23/2004WO2002095003A3 Phytases, nucleic acids encoding them and methods for making and using them
09/23/2004WO2002093127A3 Methods and reagents for identifying insulin response modulators and therapeutic uses therefor
09/23/2004US20040187170 Characterisation of gene function using double stranded RNA inhibition
09/23/2004US20040186362 Membrane for use with implantable devices
09/23/2004US20040186359 Afinity biosensor for monitoring biological process
09/23/2004US20040186281 Nucleotide derivative and DNA microarray
09/23/2004US20040186277 Process for the preparation in pure form of the protease activating blood clotting factor VII, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography
09/23/2004US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents
09/23/2004US20040186274 Methylation of histone h4 at arginine 3
09/23/2004US20040186071 Oligonucleotides or polynucleotides; screening for a drug candidate of an immunomodulator for CD40; reducing IL-12 cytokine production, treating inflammation disease; peptide nucleotide acid, modified nucleotides
09/23/2004US20040185575 via analyzing matrix metalloenzyme/proteinase activity in follicular fluid; artificial insemination
09/23/2004US20040185568 Fluid for enhancing storage stability and prevents deterioration or detachment of biosensors
09/23/2004US20040185565 High throughput system for producing recombinant viruses using site-specific recombination
09/23/2004US20040185563 Antigen presenting cells, method for their preparation and their use for cancer vaccines
09/23/2004US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering
09/23/2004US20040185533 Corticotropin-releasing factor2 receptors
09/23/2004US20040185530 Novel thermophilic polymerase III holoenzyme
09/23/2004US20040185528 Method for improved protein expression in bacteria by monitoring and modulating protein folding
09/23/2004US20040185520 Compounds and methods for detecting tripeptidyl protease I
09/23/2004US20040185519 Calcium-independent phospholipase A2 induces ischemic ventricular arrhythmias and decreases infarction size
09/23/2004US20040185518 Excitation ratiometric fluorescent biosensor for zinc ion at picomolar levels
09/23/2004US20040185517 Reaction side of which has polymer which increases opacity; acrylic latex, polystyrene sodium sulfate; reagent comprising a color indicator system (3-phenylimino-3H-phenothiazines and 3-phenylimino-3H-phenoxazines)
09/23/2004US20040185508 Methods and reagents for modulating cholesterol levels
09/23/2004US20040185504 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization
09/23/2004US20040185503 Administering peroxisome proliferator-activated receptor agonist; assaying substance for up-regulating the expression of fatty acid-binding protein; glomerulonephritis, nephrotic syndrome, focal glomerulosclerosis
09/23/2004US20040185497 Method and kit for the screening, the detection and/or the quantification of transcriptional factors
09/23/2004US20040185496 Anti-bacterial methods and materials
09/23/2004US20040185495 Methods and reagents for identifying rare fetal cells in the maternal circulation
09/23/2004US20040185492 DNA chip, PNA chip, and their preparation methods
09/23/2004US20040185490 Identification of alleles
09/23/2004US20040185489 Gene transcription assay method
09/23/2004US20040185488 Methods and compositions for diagnosing bovine paratuberculosis
09/23/2004US20040185487 Mutations in human glutamate carboxypeptidase II gene impacting folate metabolism, and detection of affected individuals
09/23/2004US20040185486 Local-global alignment for finding 3D similarities in protein structures
09/23/2004US20040185485 Gene markers useful for detecting skin damage in response to ultraviolet radiation
09/23/2004US20040185484 by fragmenting DNA; polishing the fragments' ends; ligating to universal adaptors, performing strand displacement and extension of the nicked fragments, purifying the double-stranded ligation products; solid phase synthesis
09/23/2004US20040185481 Testing method using DNA microarray
09/23/2004US20040185480 Method of treating surface of substrate used in biological reaction system
09/23/2004US20040185478 kits for quantitative analysis using genetically engineered escherichia for susceptibility testing
09/23/2004US20040185477 uses tagged primer extension in which a set of tag sequences correspond to the identity of the elected target DNA sequence; polymerase chain reaction (PCR); kits
09/23/2004US20040185476 antibody microarray for detecting incomplete deprotection of synthetic test oligonucleotides; high throughput assay; solid phase synthesis
09/23/2004US20040185475 Methods for genotyping ultra-high complexity DNA
09/23/2004US20040185474 Method of diagnosing depression
09/23/2004US20040185471 comprises evaluating one or more of the individuals of the plurality of sibships for Alzheimer's disease, cancer, or ocular disease; genetic engineering
09/23/2004US20040185470 Nucleic acid detection
09/23/2004US20040185468 Promoter variants of the alpha-7 nicotinic acetylcholine receptor
09/23/2004US20040185467 single nucleotide polymorphisms can be detected with a large differential in binding energy using short probes by virtue of localizing the base to be interrogated with flanking particulate labels
09/23/2004US20040185466 to detect single nucleotide polymorphisms, genetic mutation, gene expression, forensic identification, disease association, DNA/genomic sequencing and translation/transcription analysis; solid phase synthesis
09/23/2004US20040185465 for diagnosing a disease in an animal or susceptibility to a disease related to an over-expression of a phosphodiesterase; for drug screening antiinflammatory agents
09/23/2004US20040185464 for drug screening by detecting chemiluminescent signals; microarrays; solid phase synthesis
09/23/2004US20040185463 for drug screening which inhibit activation of cAMP and mitogen responsive genes and methods for the identification of novel signal dependent transcription factors and co-factor proteins
09/23/2004US20040185462 Method of and detecting apparatus and detecting chip for single base substitution SNP and point mutation of genes
09/23/2004US20040185461 can be improved by providing stem-loop structures, in which the terminal regions (stems) cannot hybridize with any target polynucleotide that partially hybridizes with any other part of the structure; solid phase synthesis
09/23/2004US20040185460 kits for drug screening by gel-shift assay, western blot, phage-based expression cloning, co-fractionation by chromatography, co-precipitation, cross linking, interaction trap/two hybrid analysis, and enzyme linked immunosorbent assay (ELISA)
09/23/2004US20040185459 Diagnostic nucleotide/protein sequences for monitoring and identifying restriction fragment length polymorphisms
09/23/2004US20040185457 Method for detecting dna polymerisation
09/23/2004US20040185455 kits comprising chimeric oligonucleotide primer for amplifying a target nucleic acid; solid phase synthesis
09/23/2004US20040185454 using in situ hybridization and polypeptide-based methods, such as enzyme-linked immunosorbent assay
09/23/2004US20040185453 Affinity based methods for separating homologous parental genetic material and uses thereof